Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.5 is now displayed, indicating an update to the study record. This appears to be an administrative maintenance update rather than a substantive change to the study data or eligibility.SummaryDifference0.0%

- Check16 days agoChange DetectedA new Hangzhou site in Zhejiang, China (310009) with status Completed was added on 2026-07-30, and an existing Hangzhou site (310016) with status Active, not recruiting was removed on 2026-07-14. These changes update the study's site roster and reflect shifting enrollment activity.SummaryDifference0.2%

- Check23 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous v3.6.3 tag to reflect an updated version of the page.SummaryDifference0.0%

- Check30 days agoChange DetectedDifference0.2%

- Check44 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a minor revision to the study record. The change updates the metadata or formatting without altering the study data.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's underlying system. No visible changes to study content or layout are expected.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.